MED vs NEM · rev $152.4M vs P/E 14, rev $13.43B
MEDIFAST INC (MED) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
MEDIFAST INC (MED) is a personal services company listed on NYSE.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported MED revenue for 2026-06-30 was $152.4M. Net income was -$5.2M. MED currently screens at market cap $125.3M.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
MED currently screens at market cap $125.3M. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the MED and NEM stock pages for the full models.
Not investment advice.